98 related articles for article (PubMed ID: 1346026)
1. Usefulness of bone-marrow biopsy during induction therapy for acute myeloid leukemia.
Shamdas GJ; Garewal HS; Roe DJ
Lancet; 1992 Jan; 339(8786):178. PubMed ID: 1346026
[No Abstract] [Full Text] [Related]
2. Bone marrow biopsy during induction chemotherapy for acute myeloid leukaemia identifies only 50% of patients with resistant disease.
Roberts MM; Juttner CA; To LB; Kimber RJ
Leuk Res; 1988; 12(10):817-21. PubMed ID: 3199841
[TBL] [Abstract][Full Text] [Related]
3. Idarubicin is superior to daunorubicin in remission induction of de novo acute myeloid leukemia patients with high MDR1 expression.
Shi P; Zha J; Guo X; Chen F; Fan Z; Huang F; Meng F; Liu X; Feng R; Xu B
Pharmacogenomics; 2013 Jan; 14(1):17-23. PubMed ID: 23252945
[TBL] [Abstract][Full Text] [Related]
4. Induction of Acute Myeloid Leukemia with Idarubicin, Cytarabine and Cladribine.
Wiedower E; Jamy O; Martin MG
Anticancer Res; 2015 Nov; 35(11):6287-90. PubMed ID: 26504064
[TBL] [Abstract][Full Text] [Related]
5. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
[No Abstract] [Full Text] [Related]
6. Control of acute myeloid leukemia morbidity in northwest Iran.
Eivazi-Ziaei J
Asian Pac J Cancer Prev; 2005; 6(4):472-3. PubMed ID: 16435994
[TBL] [Abstract][Full Text] [Related]
7. Etoposide in remission induction of adult acute myeloid leukemia.
Leoni F; Ciolli S; Patriarchi S; Morfini M; Rossi Ferrini P
Acta Haematol; 1990; 83(2):82-5. PubMed ID: 2106200
[TBL] [Abstract][Full Text] [Related]
8. The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukaemia: an update.
Chang J; Morgenstern GR; Coutinho LH; Scarffe JH; Carr T; Deakin DP; Testa NG; Dexter TM
Bone Marrow Transplant; 1989 Jan; 4(1):5-9. PubMed ID: 2647188
[TBL] [Abstract][Full Text] [Related]
9. [The first results of treatment for adult acute myeloid leukemia according to the AML-01.10 protocol of the Research Group of the Hematology Centers of Russia].
Parovichnikova EN; Kliasova GA; Sokolov AN; Troitskaia VV; Kokhno AV; Kuz'mina LA; Shaforostova II; Ryzhko VV; Kravchenko SK; Bondarenko SN; Lapin VA; Pristupa AS; Konstantinova TS; Zagoskina TP; Ialykomov IV; Moskov VI; Anchukova LV; Kaporskaia TS; Volodicheva EM; Kaplanov KD; Kondakova EV; Samoĭlova OS; Gavrilova LV; Kulikov SM; Savchenko VG
Ter Arkh; 2012; 84(7):10-5. PubMed ID: 23038965
[TBL] [Abstract][Full Text] [Related]
10. [A case of acute nonlymphocytic leukemia with leukemic cell infiltration to the uterus followed by bone marrow relapse].
Shiga Y; Shichishima T; Aikawa K; Gotoh J; Furukawa T; Yamagiwa A; Ishibashi T; Maruyama Y
Rinsho Ketsueki; 1994 May; 35(5):501-5. PubMed ID: 8028198
[TBL] [Abstract][Full Text] [Related]
11. Oscillations of marrow culture growth in acute myeloid leukemia during remission induction and remission.
Gustavsson A; Olofsson T; Olsson I
Acta Haematol; 1979; 62(5-6):241-6. PubMed ID: 121664
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy in acute myelogenous leukemia: high dose, higher expectations?
Berman E
J Clin Oncol; 1995 Jan; 13(1):1-4. PubMed ID: 7799008
[No Abstract] [Full Text] [Related]
13. Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia.
Stone RM; Mazzola E; Neuberg D; Allen SL; Pigneux A; Stuart RK; Wetzler M; Rizzieri D; Erba HP; Damon L; Jang JH; Tallman MS; Warzocha K; Masszi T; Sekeres MA; Egyed M; Horst HA; Selleslag D; Solomon SR; Venugopal P; Lundberg AS; Powell B
J Clin Oncol; 2015 Apr; 33(11):1252-7. PubMed ID: 25732165
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia presenting as erythema nodosum: A case report.
Xu X; Liang G; Duan M; Zhang L
Medicine (Baltimore); 2017 Nov; 96(47):e8666. PubMed ID: 29381943
[TBL] [Abstract][Full Text] [Related]
15. Predicting remission outcome in acute non-lymphocytic leukemia: general principles and their application to residual marrow leukemia.
Browman GP; Preisler HD
Leuk Res; 1992; 16(5):511-9. PubMed ID: 1625477
[TBL] [Abstract][Full Text] [Related]
16. Nine years interval between first and second bone marrow transplantations and subsequent long-term survival--a case of acute myeloid leukemia with MLL-AF6 fusion gene.
Yokoyama Y; Suzukawa K; Okoshi Y; Nanmoku T; Obara N; Enami T; Hasegawa Y; Chiba S
Ann Hematol; 2012 Sep; 91(9):1491-3. PubMed ID: 22307741
[No Abstract] [Full Text] [Related]
17. Continuous intravenous administration of daunorubicin and cytarabine for remission induction of poor risk acute myelogenous leukaemias and myelodysplastic syndromes.
Bär BM; de Witte T; de Pauw BE; Haanen C
Neth J Med; 1990 Feb; 36(1-2):19-24. PubMed ID: 2314517
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT Group.
Reiffers J; Stoppa AM; Rigal-Huguet F; Michallet M; Marit G; Gastaut JA; Attal M; Corront B; Broustet A; Hollard D
Bone Marrow Transplant; 1991; 7 Suppl 2():36. PubMed ID: 1878709
[No Abstract] [Full Text] [Related]
19. Treatment of acute myeloid leukemia in older adults: time to reflect?
Ravandi F
Leuk Lymphoma; 2006 Apr; 47(4):579-80. PubMed ID: 16886271
[No Abstract] [Full Text] [Related]
20. [Treatment of acute myeloid leukemia in adults with a combination of daunomycin and cytosine-arabinoside].
Brincker H
Ugeskr Laeger; 1972 Oct; 134(42):2195-200. PubMed ID: 4563112
[No Abstract] [Full Text] [Related]
[Next] [New Search]
